Levi & Korsinsky Notifies Investors With Losses on Their Investment in Avon Products, Inc. of Class Action Lawsuit and the September 6, 2011 Lead Plaintiff Deadline

NEW YORK, NY--(Marketwire - Jul 15, 2011) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Avon Products, Inc. ("Avon" or the "Company") (NYSE: AVP) who purchased between July 31, 2006 through May 24, 2011 (the "Class Period").

For more information, click here: http://zlk.9nl.com/avon-products/.

The complaint alleges that during the Class Period, defendants misled investors as to the breadth of potential violations of the Foreign Corrupt Practices Act (FCPA) allegedly perpetrated by the Company. A May 4, 2011 article in the Wall Street Journal reported that an internal investigation discovered that the Company may have made improper payments to officials in multiple countries. In 2010 four executives were suspended after their involvement in instances of improper expenses was discovered. According to reports, the Company has spent more than a billion on the ongoing investigation.

If you are a member of the class and suffered a loss in Avon stock, you have until September 6, 2011 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery is not affected by the decision whether or not to serve as a lead plaintiff. To obtain additional information about your rights, contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (877) 363-5972, or visit http://www.zlk.com/avon-products-avp.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.